TABLE 2.
The synergy testing results of antifungal drugs against C. krusei planktonic cells based on the fractional inhibitory concentration index (FICI) values.
(a) | |||||||||
MIC (μ g/mL) of |
MIC (μ g/mL) of |
||||||||
ID | AMB | MIL | AMB/MIL | FICIa | ID | AMB | MIL | AMB/MIL | FICIa |
3 | 2 | 2 | 0.25/1 | 0.63 | 37 | 2 | 2 | 0.25/1 | 0.63 |
11 | 2 | 2 | 0.5/0.5 | 0.5 | 39 | 2 | 2 | 0.25/1 | 0.63 |
17 | 2 | 1 | 0.25/1 | 1.13 | 41 | 2 | 2 | 0.5/0.5 | 0.5 |
21 | 2 | 2 | 0.25/1 | 0.63 | 42 | 4 | 2 | 0.5/1 | 0.63 |
24 | 2 | 2 | 0.25/1 | 0.63 | 45 | 2 | 2 | 0.125/0.5 | 0.38 |
25 | 2 | 2 | 0.25/1 | 0.63 | 47 | 2 | 2 | 0.25/1 | 0.63 |
27 | 2 | 2 | 0.25/1 | 0.63 | 49 | 2 | 2 | 0.5/0.5 | 0.5 |
30 | 1 | 2 | 0.125/0.5 | 0.38 | 51 | 2 | 2 | 0.25/1 | 0.63 |
32 | 2 | 2 | 0.25/1 | 0.63 | 54 | 2 | 2 | 0.25/1 | 0.63 |
34 | 2 | 2 | 0.25/1 | 0.63 | 57 | 2 | 2 | 0.25/1 | 0.63 |
(b) | |||||||||
MIC (μ g/mL) of |
MIC (μ g/mL) of |
||||||||
ID | FLC | MIL | FLC/MIL | FICIa | ID | FLC | MIL | FLC/MIL | FICIa |
3 | 32 | 2 | >16/>1 | 2 | 37 | 128 | 2 | >64/>1 | 2 |
11 | 16 | 2 | >8/>1 | 2 | 39 | 64 | 2 | >32/>1 | 2 |
17 | 32 | 1 | >16/>0.5 | 2 | 41 | 64 | 2 | >32/>1 | 2 |
21 | 32 | 2 | >16/>1 | 2 | 42 | 128 | 2 | >64/>1 | 2 |
24 | 64 | 2 | >32/>1 | 2 | 45 | 64 | 2 | >32/>1 | 2 |
25 | 32 | 2 | >16/>1 | 2 | 47 | 64 | 2 | >32/>1 | 2 |
27 | 32 | 2 | >16/>1 | 2 | 49 | 32 | 2 | >16/>1 | 2 |
30 | 64 | 2 | >32/>1 | 2 | 51 | 32 | 2 | >16/>1 | 2 |
32 | 32 | 2 | >16/>1 | 2 | 54 | 32 | 2 | >16/>1 | 2 |
34 | 32 | 2 | >16/>1 | 2 | 57 | 64 | 2 | >32/>1 | 2 |
aFICI values in bold indicate synergy. AMB, amphotericin B; FLC, fluconazole; MIL, miltefosine.